More than three decades later, we remain committed in pursuit of pharmaceutical innovation, providing high quality products and strive to deliver superior business results. Mercury Pharmaceuticals thrives to maintain an environment built on mutual respect and individual integrity. This includes our customers we serve, employees, shareholders, partners, suppliers and communities.
Mercury Pharmaceuticals manufacturing solutions include contract biomanufacturing services, bioprocess development and purification equipment.
We have unique manufacturing capabilities and a track record for viruses and viral vectors (lentivirus, AAV, ADV, etc.) for gene therapy and vaccination, and experience in manufacturing monoclonal antibodies including: conjugation, mAb fragments and other rec-proteins from fermentation and cell culture for a broad range of therapeutic indications. We can also provide you with purification process development, along with preparative and industrial purification equipment for biologic and small biomolecule manufacturing including LPLC, continuous chromatography, and tailor-made TFF systems.
With history in traditional medicine, we have developed several drug products isolated from plant extracts.
We are always thriving to maintain on our core values at Mercury Pharmaceuticals, we embrace the principles of good corporate governance, implemented through strong, independent and diverse membership on our team. We are consistently implementing the best governance practices, it is more important than ever that we continually earn our investor's confidence. We will do this by remaining a leader in corporate governance and providing clear, consistent and truthful communication about our performance.
Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more
Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more
Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more
9
Dec 2025
Adults with autism spectrum disorder (ASD) and other neurodevelopmental disorders (NDDs) often lose access to specialized care once they age out of pediatric services.
9
Dec 2025
Blinking is a human reflex most often performed without thinking, like breathing. Although research on blinking is usually related to vision, a new Concordia study examines how blinking is connected to cognitive function such as filtering out background noise to focus on what someone is trying to say to us in a crowded room.
9
Dec 2025
Southwest Research Institute (SwRI) and Trinity University are developing an intranasal (IN) drug-device combination to treat post-traumatic stress disorder (PTSD).
9
Dec 2025
This study shows that vacancy-engineered MoS₂ nanoflowers drive mitochondrial biogenesis in human mesenchymal stem cells by activating SIRT1–PGC-1α signaling and reducing oxidative stress. These treated cells transfer more functional mitochondria to injured recipient cells, restoring energy metabolism and redox balance in multiple in vitro models.